One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Cardiovascular Complications of Chronic Rheumatic Diseases
GEORGE A. KARPOUZAS
doi : 10.1016/S0889-857X(22)00094-1
Volume 49, Issue 1, February 2023, Page i
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases
Michael H. Weisman, MD
doi : 10.1016/j.rdc.2022.09.002
Volume 49, Issue 1, February 2023, Pages xiii-xiv
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases
George A. Karpouzas, MD M. Elaine Husni, MD, MPH
doi : 10.1016/j.rdc.2022.09.001
Volume 49, Issue 1, February 2023, Pages xv-xvi
Time Trends of Cardiovascular Disease in the General Population and Inflammatory Arthritis
Anna S?dergren, MD, PhD a,b, *, Solbritt Rantap??-Dahlqvist, MD, PhD a , Lotta Ljung, MD, PhD
doi : 10.1016/j.rdc.2022.07.003
Volume 49, Issue 1, February 2023, Pages 1-17
Atherosclerotic Cardiovascular Risk Stratification in the Rheumatic Diseases:: An Integrative, Multiparametric Approach
Durga Prasanna Misra, DM, MRCP(UK), FRCP(Edin) a , Ellen M. Hauge, MD, PhD b , Cynthia S. Crowson, PhD c , George D. Kitas, MD, PhD d , Sarah R. Ormseth e , George A. Karpouzas, MD e, *
doi : 10.1016/j.rdc.2022.07.004
Volume 49, Issue 1, February 2023, Pages 19-43
Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases
Alexia A. Zagouras, MD, MA a , W.H. Wilson Tang, MD
doi : 10.1016/j.rdc.2022.08.002
Volume 49, Issue 1, February 2023, Pages 45-66
Heart Failure in Rheumatic Disease: Secular Trends and Novel Insights
Brian Bridal L?gstrup,
doi : 10.1016/j.rdc.2022.08.003
Volume 49, Issue 1, February 2023, Pages 67-79
Cardiovascular Disease in Large Vessel Vasculitis: Risks, Controversies, and Management Strategies
Alison H. Clifford,
doi : 10.1016/j.rdc.2022.08.004
Volume 49, Issue 1, February 2023, Pages 81-96
Venous Thromboembolism in the Inflammatory Rheumatic Diseases
Durga Prasanna Misra, DM, MRCP(UK), FRCP(Edin) a, *, Sakir Ahmed, DM b , Mohit Goyal, MD, FRCP(Edin) c , Aman Sharma, MD, FRCP(London) d , Vikas Agarwal, DM, FRCP(Edin
doi : 10.1016/j.rdc.2022.08.001
Volume 49, Issue 1, February 2023, Pages 97-127
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases
Ivana Hollan,
doi : 10.1016/j.rdc.2022.07.005
Volume 49, Issue 1, February 2023, Pages 129-150
Role of Lipoprotein Levels and Function in Atherosclerosis Associated with Autoimmune Rheumatic Diseases
Nicoletta Ronda, MD, PhD a, *, Francesca Zimetti, PhD a , Maria Pia Adorni, PhD b , Marcella Palumbo, ScD a , George A. Karpouzas, MD c , Franco Bernini, PhD
doi : 10.1016/j.rdc.2022.07.006
Volume 49, Issue 1, February 2023, Pages 151-163
Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis
Brittany Weber, MD, PhD a,b, *, Katherine P. Liao, MD, MPH
doi : 10.1016/j.rdc.2022.08.005
Volume 49, Issue 1, February 2023, Pages 165-178
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk: Decades Later, Any New Lessons Learned?
Deeba Minhas, MD a, *, Anjali Nidhaan, MD b , M. Elaine Husni, MD, MPH
doi : 10.1016/j.rdc.2022.08.006
Volume 49, Issue 1, February 2023, Pages 179-191
